<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d15">
    <sentence id="DDI-DrugBank.d15.s0" text="In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.">
        <entity id="DDI-DrugBank.d15.s0.e0" charOffset="35-46"
            type="drug" text="Fondaparinux"/>
        <entity id="DDI-DrugBank.d15.s0.e1" charOffset="77-90"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d15.s0.e2" charOffset="93-100"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d15.s0.e3" charOffset="104-122"
            type="group" text="platelet inhibitors"/>
        <entity id="DDI-DrugBank.d15.s0.e4" charOffset="125-144"
            type="drug" text="acetylsalicylic acid"/>
        <entity id="DDI-DrugBank.d15.s0.e5" charOffset="148-153"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d15.s0.e6" charOffset="156-164"
            type="drug" text="piroxicam"/>
        <entity id="DDI-DrugBank.d15.s0.e7" charOffset="172-178"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d15.s0.e8" charOffset="250-268"
            type="drug" text="fondaparinux sodium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d15.s1" text="In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.">
        <entity id="DDI-DrugBank.d15.s1.e0" charOffset="13-24"
            type="drug" text="Fondaparinux"/>
        <entity id="DDI-DrugBank.d15.s1.e1" charOffset="69-76"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d15.s1.e2" charOffset="79-98"
            type="drug" text="acetylsalicylic acid"/>
        <entity id="DDI-DrugBank.d15.s1.e3" charOffset="101-109"
            type="drug" text="piroxicam"/>
        <entity id="DDI-DrugBank.d15.s1.e4" charOffset="116-122"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d15.s1.e5" charOffset="153-159"
            type="drug" text="digoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d15.s2" text="Agents that may enhance the risk of hemorrhage should be discontinued prior to initiation of Fondaparinux therapy.">
        <entity id="DDI-DrugBank.d15.s2.e0" charOffset="93-104"
            type="drug" text="Fondaparinux"/>
    </sentence>
    <sentence id="DDI-DrugBank.d15.s3" text="If co-administration is essential, close monitoring may be appropriate."/>
    <sentence id="DDI-DrugBank.d15.s4" text="In an in vitro study in human liver microsomes, inhibition of CYP2A6 hydroxylation of coumarin by fondaparinux (200 m m M i.e., 350 mg/L) was 17-28%.">
        <entity id="DDI-DrugBank.d15.s4.e0" charOffset="86-93"
            type="group" text="coumarin"/>
        <entity id="DDI-DrugBank.d15.s4.e1" charOffset="98-109"
            type="drug" text="fondaparinux"/>
        <ddi id="DDI-DrugBank.d15.s4.d0" e1="DDI-DrugBank.d15.s4.e0"
            e2="DDI-DrugBank.d15.s4.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d15.s5" text="Inhibition of the other isozymes evaluated (CYPs 2A1, 2C9, 2C19, 2D6, 3A4, and 3E1) was 0-16%."/>
    <sentence id="DDI-DrugBank.d15.s6" text="Since fondaparinux does not markedly inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4) in vitro, fondaparinux sodium is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes.">
        <entity id="DDI-DrugBank.d15.s6.e0" charOffset="6-17"
            type="drug" text="fondaparinux"/>
        <entity id="DDI-DrugBank.d15.s6.e1" charOffset="124-142"
            type="drug" text="fondaparinux sodium"/>
    </sentence>
    <sentence id="DDI-DrugBank.d15.s7" text="Since fondaparinux sodium does not bind significantly to plasma proteins other than ATIII, no drug interactions by protein-binding displacement are expected.">
        <entity id="DDI-DrugBank.d15.s7.e0" charOffset="6-24"
            type="drug" text="fondaparinux sodium"/>
    </sentence>
</document>
